Paola Lanati is the new vice president of Italian Angels for Biotech. Lanati has consolidated experience in the business world in the life sciences sector, his contribution to the IAB Association serves to face the challenges and seize the opportunities that the life sciences sector offers. Lanati, after exiting in 2022 with his group of leading life science consulting companies sold to Cencora (NYSE), founded two startups, Indicon SB, active in life science innovation management, and Lionhealth SB, focused on medical nutrition; after exiting, she invested in eight startups and in 2023 she was among the four finalists of the Business Angel of the Year Award, organized by the Investors Club.
In line with the vision shared with Paola Lanati, IAB intends to further strengthen its commitment to involve an increasing number of players in the sector, improve synergies with strategic partners and expand the network of collaborations.
Luca Benatti, president and founder of Italian Angels for Biotech says in a statement: “We welcome with great pleasure the entry of Lanati into the board of IAB and his appointment as vice president. His skills, track record and energy will be key to making a decisive contribution to the growth and consolidation of our association.”
Paola Lanati, new vice president of Italian Angels for Biotech adds: “I am honored to have been appointed by the IAB board of directors as vice president of the Association. I started doing Business Angel in 2022, focusing on the Lifescience market, where I have been working for 25 years. I believe that the role of business angels should be strengthened in our country, as we are the first investors to intervene in the initial stages of supporting startups. Our sector requires very specific skills, which is why the role of IAB is key in the technology transfer phase, in the early stage, for life science startups to be successful. My commitment is to make known as much as possible what it means to be a business angel, for the added value both for business angels and for startups that receive resources and skills”.
About IAB
Italian Angels for Biotech is the association founded in 2015 to help bridge the Italian gap between scientific excellence and value creation, through financial investments and managerial support to industrial projects. The association has participated in numerous successful rounds, including Metis Precision Medicine, MGShell, CasRevolution. Today IAB is composed of the members of the board of directors: Luca Benatti, TES Pharma; Federica Draghi, Xgen Venture; Paolo Fundarò, Xgen Venture; Giovanni Rizzo, Indigo Venture; Chiara Zambon, Zambon Company, and more than 30 professionals in the life sciences sector.
ALL RIGHTS RESERVED ©